Drugs / KRC-01
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07622017 | Jul 2026 → Jan 2029 expected | rectal cancer | Gustave Roussy, Cancer Campus, Grand Paris | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KRC-01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07622017 ↗ |
| Known as | KORTUC | “KRC-01 (KORTUC)” NCT07622017 ↗ |
| Route | Other | “is injected directly into the tumor before radiotherapy sessions” NCT07622017 ↗ |